Photo from ESMO/LinkedIn
Jul 28, 2024, 10:33
Breaking Science in Gastrointestinal Cancers with Giovanni Randon – ESMO
ESMO – European Society for Medical Oncology shared on LinkedIn:
“For ESMO members: Breaking Science in Gastrointestinal Cancers.
Giovanni Randon presents Switch maintenance with ramucirumab plus paclitaxel in advanced HER2-negative gastric/GEJ cancer.
Discover this video and more in the series on OncologyPRO now.”
Source: ESMO/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 19:25
Nov 13, 2024, 16:51
Nov 13, 2024, 16:49
Nov 13, 2024, 16:45
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23
Nov 13, 2024, 16:08